PLX

#3751
Protalix BioTherapeutics, Inc. Common Stock
2.1250 USD
+0.24%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
2.1150
2.1400
Year Range
2.0300
3.1900
Daily Change
+0.24%
Monthly Change
+0.34%
6 month change
-27.23%
Year Change
-27.23%
Previous Close
2.1200
Open
2.1250
Low
2.1150
High
2.1400
Volume
264
Open full chart

Financials

Overview Statement Statistics
Quarterly Annual
Income statement Balance sheet Cash flow
Value 202020212022202320242025 TTM

Protalix BioTherapeutics Inc (DE)

Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease.

News